A new drug to treat Alzheimer's disease has promising results

As a result of clinical trials, a drug has been successful in reducing brain damage in patients with Alzheimer's disease. According to findings released by the International Conference of the Alzheimer's Association in Chicago, the drug could be the first of its kind to manage changes in the brain as well as the symptoms of Alzheimer's disease. "Clinical trials show changes in injuries and cognition," said Dr. Reisa Sperling, director of the Alzheimer's Research and Treatment Center in Brigham, who was not involved in the study.

The NY Times writes that Apart from a few medications that slow the decline of memory for several months, there is no effective treatment for Alzheimer's disease, a disease that affects 44 million people in the world. It is estimated that these numbers will triple by 2050.

850 American, European and Japanese patients with early symptoms of cognitive decline participated in the tests. They have been diagnosed with early cognitive impairment or dementia, with deposits of amyloid proteins in the brain. The drug called BAN 2401 was created by a Japanese company in collaboration with Biogen, a Cambridge company.

Source: descopera.ro